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To tackle the huge problem of mental illness, England has launched a large programme of
psychological therapy, which is being watched worldwide. The authors argue that it costs nothing,
due to savings on welfare benefits and physical healthcare. The article is based on the recent book
Thrive: The power of evidence-based psychological therapies (Layard and Clark, 2014b).
In rich countries 38% of all illness is mental illness (p. 43–45, Layard and Clark, 2014b). It
particularly affects people of working age where it accounts for 50% of the total (see Figure 1).
The overall economic cost has been estimated at 8% of GDP, not to mention the massive suffering
involved. Policy-makers increasingly wonder what they can do about it.
Fortunately the last 40 years have seen huge progress in evidence-based psychological therapies
especially cognitive-behavioral therapy (CBT). For people with clinical depression or chronic
anxiety disorders this leads to 50% recovery rates, with many others also improving substantially.
It also halves the likelihood of relapse; in this respect it is more effective than drugs. It is also what
the great majority of patients would prefer (Mchugh et al., 2013).
Yet in most countries only a tiny minority of people with depression or anxiety disorders
get evidence-based psychological therapy, meaning a therapy supported by the Cochrane
Collaboration or Britain’s National Institute for Health and Care Excellence (NICE). In Britain
in 2007 one in six people (surveyed in their homes) met the diagnostic criteria for depression or
anxiety disorders like OCD, PTSD, panic disorder or social anxiety disorder. Of those, 1% received
evidence-based psychological therapy. The situation is much better today in England thanks to a
major programme of training and service development called Improving Access to Psychological
Therapies (IAPT) which began in 2008. By now it is assessing about 13% of the diagnosable
population, and treating about 8%—nearly half a million people. It has been called world-beating
in the journal Nature. But still the whole country is not covered and waiting times are dangerously
long. The authors and many others are arguing that the programme needs to double by 2020.
A central issue has always been cost, and one appeal of the programme to policy-makers has been
the cost savings which it generates. Averaged over all patients from mild to severe and all lengths
of treatment (from those who drop out after two sessions to those who get up to 20 sessions), the
cost per patient is £650. Against this we have to set the savings on, first, welfare benefits, and then
physical healthcare.
As we have mentioned, mental illness is the main illness of working age. In most rich countries
about 1% of the working age population are on disability benefits due to depression or anxiety
disorders. In Britain one such person costs the government £650 a month more than if they were
not on benefit (This includes both the benefits and reduced tax payments; Department for Work
Pensions, 20141). So suppose we treat a representative group of people with depression or anxiety
disorders. If as a result of treatment 4% of those treated worked an extra 25 months, the average
patient would be working 1 month more than otherwise. This would be enough to repay the cost
of the treatment.
1Available online at: https://www.gov.uk/government/organisations/department-for-work-pensions
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FIGURE 1 | Mental illness is the main health problem of working age in
rich countries.
Is 4% a realistic estimate? A number of randomized trials in
the US and Britain come up with much larger numbers (Layard
and Clark, 2014b). So, more psychological therapy is hugely in
the interest of Finance Ministries worldwide.
But on top of this there is another equally important area
of savings—on physical healthcare. Suppose we take 2 people
with the same type and degree of physical illness, but A also
has depression or an anxiety disorder. Then A will get around
50% more physical healthcare than B—partly because of the
physiological effects of mental illness, partly because of unhealthy
habits, and partly due to extra levels of anxiety. Figure 2 shows
some striking figures on the effects of depression from the
Colorado Access insurance scheme.
In Britain the cost of physical healthcare is around £2000
extra when the patient is also mentally ill. So if we treat a
physically ill person for their mental illness we can expect to
save up to £1000 a year on physical healthcare (due to the
50% recovery rate). One enterprising British general medical
practice has in fact tracked the physical healthcare costs of its
mentally ill patients and found similar results. They tracked all
their mentally ill patients and compared those who had been
treated by the IAPT programme with those who had not. The
difference in physical healthcare costs was about £750 a year.
This compares with the one-off cost of £650 for the psychological
therapy.
Of course not all mentally ill people have physical problems,
though over 50% do. But in England the biggest future expansion
of psychological therapy will be among people who also have
physical problems. In such cases the savings are even greater
if the psychological therapy is explicitly tailored to take into
account the physical problem—such as breathlessness, heart pain
or back pain. Numerous innovations of this kind have shown
huge savings in the cost of physical healthcare—often up to four
times the cost of the psychological therapy (Gulliksson et al.,
2011). For example, Figure 3 shows the progress of Swedish
patients discharged from hospital following a heart attack. One
set of patients was given group CBT in 20 sessions over a year,
the other was given none.
We can summarize our cost findings in Table 1. In most
countries the savings in benefits and taxes accrue to the public
finances, and may be of little interest to those who finance
FIGURE 2 | Depression increases the cost of physical healthcare.
FIGURE 3 | CBT reduces the recurrence of cardiovascular disease. All
readings are adjusted for initial medical condition.
TABLE 1 | Costs and savings from psychological therapy (England).
Cost £650 (one-off)
Savings in welfare benefits and extra taxes > £650 (within 2 years)
Savings in reduced physical healthcare > £650 (per year, duration unknown)
healthcare. But the healthcare savings accrue to exactly the same
authorities as finance the psychological therapy (in Britain the
National Health Service and in most other countries the health
insurance system).
Against this background the case for expanding psychological
therapy is surely overwhelming. It responds to a huge problem.
It is effective. It would cost nothing to the system. And it would
relieve a mass of suffering (Layard and Clark, 2014a).
AUTHOR NOTE
This contribution is a modified version of the article “Why
more psychological therapy would cost nothing” [Online]
reproduced with permission from http://www.voxeu.org/article/
psychological-therapy-costs-nothing: VOX CEPR’s Policy Portal
[Accessed 17 July 2014].
Frontiers in Psychology | www.frontiersin.org 2 November 2015 | Volume 6 | Article 1713
Layard and Clark Saving Costs with Psychological Therapies
REFERENCES
Gulliksson, M., Burell, G., Vessby, B., Lundin, L., Toss, H., and Svärdsudd,
K. (2011). Randomized controlled trial of cognitive behavioral therapy vs
standard treatment to prevent recurrent cardiovascular events in patients
with coronary heart disease: secondary prevention in uppsala primary
health care project (SUPRIM). Arch. Intern. Med. 171, 134–140. doi:
10.1001/archinternmed.2010.510
Layard, R., and Clark, D. (2014a). Why More Psychological Therapy Would Cost
Nothing. VOX CEPR’s Policy Portal. Available online at: http://www.voxeu.org/
article/psychological-therapy-costs-nothing [Accessed July 17, 2014].
Layard, R., and Clark, D. M. (2014b). Thrive: The Power of Evidence-Based
Psychological Therapies. London: Penguin.
Mchugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A.,
and Otto, M. W. (2013). Patient preference for psychological vs
pharmacologic treatment of psychiatric disorders: a meta-analytic
review. J. Clin. Psychiatry 74, 595–602. doi: 10.4088/JCP.12r
07757
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Layard and Clark. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in
this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Psychology | www.frontiersin.org 3 November 2015 | Volume 6 | Article 1713
